The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1418
June 10, 2013
View Complete Issue         Table of Contents 2019 
Issue 1418
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
In Brief: Warning Against Use of Valproate for Migraine Prevention During Pregnancy
June 10, 2013 (Issue: 1418)
The FDA is advising health care professionals not to prescribe valproate sodium (Depacon), valproic acid (Depakene, Stavzor, and generics) or divalproex sodium (Depakote, Depakote ER, and generics) for migraine prevention in pregnant women because a...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1418
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.